Back
26
48
Day Range
$105.88
$108.68
52-Week Range
$71.42
$115.33
Volume
236,539
50D / 200D Avg
$94.46
/
$88.84
Prev Close
$106.31
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (626 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 42.6 | 0.4 |
| P/B | 6.2 | 2.9 |
| ROE % | 15.8 | 3.8 |
| Net Margin % | 23.1 | 3.9 |
| Rev Growth 5Y % | 12.8 | 10.0 |
| D/E | 0.5 | 0.2 |
Key Takeaways
Revenue grew 12.75% annually over 5 years — strong growth
Earnings grew 31.10% over the past year
ROE of 15.80% — decent returns on equity
Net margin of 23.13% shows strong profitability
Debt/Equity of 0.47 — conservative balance sheet
Generating 74.47M in free cash flow
Growth
Revenue Growth (5Y)
12.75%
Revenue (1Y)13.53%
Earnings (1Y)31.10%
FCF Growth (3Y)58.92%
Quality
Return on Equity
15.80%
ROIC8.80%
Net Margin23.13%
Op. Margin27.21%
Safety
Debt / Equity
0.47
Current Ratio12.89
Interest Coverage13.10
Valuation
P/E Ratio
42.56
P/B Ratio6.24
EV/EBITDA38.49
Dividend Yield0.01%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 13.53% | Revenue Growth (3Y) | 13.58% |
| Earnings Growth (1Y) | 31.10% | Earnings Growth (3Y) | 38.48% |
| Revenue Growth (5Y) | 12.75% | Earnings Growth (5Y) | 21.03% |
| Profitability | |||
| Revenue (TTM) | 249.60M | Net Income (TTM) | 57.73M |
| ROE | 15.80% | ROA | 9.38% |
| Gross Margin | 71.53% | Operating Margin | 27.21% |
| Net Margin | 23.13% | Free Cash Flow (TTM) | 74.47M |
| ROIC | 8.80% | FCF Growth (3Y) | 58.92% |
| Safety | |||
| Debt / Equity | 0.47 | Current Ratio | 12.89 |
| Interest Coverage | 13.10 | Dividend Yield | 0.01% |
| Valuation | |||
| P/E Ratio | 42.56 | P/B Ratio | 6.24 |
| P/S Ratio | 9.84 | PEG Ratio | 1.06 |
| EV/EBITDA | 38.49 | Dividend Yield | 0.01% |
| Market Cap | 2.46B | Enterprise Value | 2.61B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 249.60M | 219.86M | 193.48M | 161.65M | 154.42M |
| Net Income | 57.73M | 44.04M | 30.11M | 20.64M | 26.91M |
| EPS (Diluted) | 2.52 | 1.93 | 1.34 | 0.93 | 1.25 |
| Gross Profit | 178.54M | 150.90M | 127.05M | 104.90M | 101.38M |
| Operating Income | 67.91M | 52.26M | 36.71M | 26.83M | 36.43M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 615.69M | 551.82M | 346.78M | 310.48M | 292.80M |
| Total Liabilities | 222.17M | 214.53M | 48.88M | 42.28M | 38.65M |
| Shareholders' Equity | 393.52M | 337.29M | 297.90M | 268.20M | 254.15M |
| Total Debt | 185.59M | 185.69M | 19.10M | 16.60M | 15.94M |
| Cash & Equivalents | 28.24M | 25.61M | 24.27M | 19.13M | 13.86M |
| Current Assets | 468.23M | 402.19M | 194.60M | 161.73M | 139.88M |
| Current Liabilities | 36.32M | 30.61M | 29.88M | 25.33M | 21.81M |
Strategy Scores
This stock passed the criteria for 2 strategies
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#879 of 1024
Custom
Balanced Risk
#62 of 148
Recent Activity
Entered
Cash Flow Compounder
Mar 24, 2026
Entered
Balanced Risk
Mar 24, 2026